Pay in 4 interest-free payments of $6.66 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
AMPK agonist alleviate renal tubulointerstitial fibrosis via activating mitophagy in high fat and streptozotocin induced diabetic mice
Liver Int 39(5):941949
Lancet Diabetes Endocrinol 5(4):271279 Wilding JPH, Batterham RL, Davies M, Van Gaal LF, Kandler K, Konakli K, Lingvay I, McGowan BM, Oral TK, Rosenstock J, Wadden TA, Wharton S, Yokote K, Kushner RF, STEP 1 Study Group (2022) Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension
51 FujimuraM.Morita-FujimuraY.KawaseM.ChanP
This combined therapy offers a comprehensive strategy, particularly for individuals whose blood sugar levels remain inadequately controlled with metformin alone, or those who could benefit from significant weight reduction alongside glycemic management
M.LoriniA.AntunesB
US$ 26.77
US$ 21.09
US$ 22.82
US$ 22.16
US$ 25.81
